Diagnostic Criteria for Hypokinetic Gallbladder
Hypokinetic (dyskinetic) gallbladder is diagnosed when a patient meets Rome III criteria for functional biliary pain AND demonstrates a gallbladder ejection fraction (GBEF) <38% on standardized CCK-cholescintigraphy. 1
Essential Diagnostic Components
1. Clinical Criteria (Rome III for Functional Gallbladder Disorder)
All of the following must be present: 1, 2
- Pain location: Right upper quadrant and/or epigastrium 2
- Duration: Episodes lasting ≥30 minutes 1, 2
- Pattern: Recurrent episodes at varying intervals (not daily) 1, 2
- Character: Pain builds to a steady level (not colicky or intermittent) 1, 2
- Severity: Severe enough to interrupt daily activities or prompt clinical visit 1, 2
- Non-responsiveness: Pain NOT relieved by bowel movements, postural changes, or antacids 1, 2
- Structural exclusion: Other structural diseases excluded 1, 2
- Gallbladder present: Patient has not undergone cholecystectomy 1, 2
- Normal laboratory values: Normal liver function tests and pancreatic enzymes 1, 2
2. Imaging Requirements
Transabdominal ultrasound must demonstrate: 1, 3
- Absence of gallstones
- No gallbladder wall thickening
- No bile duct dilation
- No other structural abnormalities
3. CCK-Cholescintigraphy (HIDA Scan) Protocol
Standardized technique is critical: 1, 3
- Sincalide dose: 0.02 μg/kg infused continuously over 60 minutes 1, 3
- Timing: Dynamic imaging (1 image per minute) throughout the 60-minute infusion 1
- Calculation: GBEF = (maximum counts - minimum counts) / maximum counts, corrected for background 1
- Measurement timepoint: GBEF calculated at 60 minutes 1
Diagnostic threshold: 1
Mandatory Pre-Test Evaluation
Before ordering CCK-cholescintigraphy: 1, 3
- Laboratory panel: AST, ALT, alkaline phosphatase, bilirubin, GGT, amylase, lipase (all must be normal) 3
- Upper endoscopy: To exclude peptic ulcer disease and gastroduodenal pathology 1, 3
- Medication review: Identify agents that impair gallbladder motility 1, 2
Critical Pitfalls to Avoid
Medications That Falsely Lower GBEF
Discontinue these before testing when clinically feasible: 1, 2, 3
- Opioid analgesics (significantly impair contractility) 1, 2
- Calcium channel blockers 1, 2
- Oral contraceptive agents 1, 2
- Histamine-2 receptor antagonists 1, 2
- Benzodiazepines 1, 2
Medical Conditions That Lower GBEF
Screen for these confounders: 1, 2
- Diabetes mellitus (causes gallbladder hypomotility) 1, 2
- Celiac disease 1, 2
- Irritable bowel syndrome 1, 2
Testing Contraindications
Do NOT perform CCK-cholescintigraphy in: 1, 3
- Patients with atypical symptoms (not meeting Rome III criteria) 1, 3
- Patients currently hospitalized or in acute pain 3
- Patients taking medications that impair motility (unless discontinued) 3
Important Technical Considerations
Pain provocation during CCK infusion has NO diagnostic value: 1
- Rapid CCK infusion (<30 minutes) causes non-specific abdominal cramping in 48-53% of patients 1
- Symptom reproduction should NOT influence interpretation 1
- The 60-minute infusion protocol minimizes non-specific symptoms 1
An abnormal GBEF is NOT specific for primary gallbladder disease: 1, 2
- May reflect sphincter of Oddi dysfunction rather than gallbladder pathology 1
- May occur in asymptomatic healthy individuals 1
- Requires appropriate clinical context for interpretation 1
Diagnostic Algorithm Summary
- Confirm Rome III criteria (all 9 components must be present) 1, 2
- Obtain normal ultrasound (no stones, no structural abnormalities) 3
- Verify normal laboratory values (liver enzymes, pancreatic enzymes) 3
- Perform upper endoscopy (exclude gastroduodenal pathology) 1, 3
- Review and discontinue interfering medications 3
- Screen for medical conditions affecting motility 2
- Perform standardized 60-minute CCK-cholescintigraphy 1, 3
- Interpret GBEF at 60 minutes: <38% = hypokinetic gallbladder 1